Anna Serquiña

568 total citations
7 papers, 457 citations indexed

About

Anna Serquiña is a scholar working on Cancer Research, Molecular Biology and Virology. According to data from OpenAlex, Anna Serquiña has authored 7 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cancer Research, 2 papers in Molecular Biology and 2 papers in Virology. Recurrent topics in Anna Serquiña's work include HIV Research and Treatment (2 papers), Extracellular vesicles in disease (2 papers) and Viral-associated cancers and disorders (2 papers). Anna Serquiña is often cited by papers focused on HIV Research and Treatment (2 papers), Extracellular vesicles in disease (2 papers) and Viral-associated cancers and disorders (2 papers). Anna Serquiña collaborates with scholars based in United States. Anna Serquiña's co-authors include Tariq M. Rana, Robin Nathans, Chih‐Chung Lu, Hong Cao, Chia‐Ying Chu, Joseph M. Ziegelbauer, Е. Н. Попова, Ogooluwa Ojelabi, Heinrich G. Göttlinger and Suman R. Das and has published in prestigious journals such as The Journal of Cell Biology, Blood and Molecular Cell.

In The Last Decade

Anna Serquiña

7 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Serquiña United States	6	286	179	129	96	70	7	457
Xiancai Ma China	11	240 0.8×	127 0.7×	142 1.1×	113 1.2×	136 1.9×	28	457
Shraddha Sharma United States	8	400 1.4×	97 0.5×	63 0.5×	65 0.7×	84 1.2×	10	515
Omar Flores United States	6	418 1.5×	282 1.6×	61 0.5×	166 1.7×	65 0.9×	7	632
Philipp Schult Germany	9	197 0.7×	76 0.4×	49 0.4×	78 0.8×	71 1.0×	13	457
Matthias Hamdorf United States	7	345 1.2×	94 0.5×	136 1.1×	92 1.0×	65 0.9×	8	512
Mayra Solis Canada	10	268 0.9×	129 0.7×	150 1.2×	468 4.9×	91 1.3×	13	683
Fiorella Rossi United States	9	124 0.4×	71 0.4×	103 0.8×	83 0.9×	98 1.4×	10	329
Ann Emery United States	9	567 2.0×	161 0.9×	140 1.1×	82 0.9×	79 1.1×	19	667
Roland H. Stauber Germany	8	246 0.9×	74 0.4×	80 0.6×	40 0.4×	119 1.7×	12	432
Karel A. van Dort Netherlands	15	216 0.8×	72 0.4×	207 1.6×	288 3.0×	106 1.5×	31	719

Countries citing papers authored by Anna Serquiña

Since Specialization

Citations

This map shows the geographic impact of Anna Serquiña's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Serquiña with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Serquiña more than expected).

Fields of papers citing papers by Anna Serquiña

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Serquiña. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Serquiña. The network helps show where Anna Serquiña may publish in the future.

Co-authorship network of co-authors of Anna Serquiña

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Serquiña. A scholar is included among the top collaborators of Anna Serquiña based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Serquiña. Anna Serquiña is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Proctor, Diana M., Nsa Dada, Anna Serquiña, & Julia L. E. Willett. (2023). Problems with Peer Review Shine a Light on Gaps in Scientific Training. mBio. 14(3). e0318322–e0318322. 7 indexed citations

2.

Tagawa, Takanobu, et al.. (2020). Viral non-coding RNAs: Stealth strategies in the tug-of-war between humans and herpesviruses. Seminars in Cell and Developmental Biology. 111. 135–147. 22 indexed citations

3.

Ramaswami, Ramya, Kathryn Lurain, Cody J. Peer, et al.. (2020). Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus–associated multicentric Castleman disease. Blood. 135(25). 2316–2319. 37 indexed citations

4.

Serquiña, Anna, et al.. (2017). Viral MicroRNAs Repress the Cholesterol Pathway, and 25-Hydroxycholesterol Inhibits Infection. mBio. 8(4). 26 indexed citations

5.

Serquiña, Anna & Joseph M. Ziegelbauer. (2017). How herpesviruses pass on their genomes. The Journal of Cell Biology. 216(9). 2611–2613. 5 indexed citations

6.

Serquiña, Anna, et al.. (2013). UPF1 Is Crucial for the Infectivity of Human Immunodeficiency Virus Type 1 Progeny Virions. Journal of Virology. 87(16). 8853–8861. 40 indexed citations

7.

Nathans, Robin, Chia‐Ying Chu, Anna Serquiña, et al.. (2009). Cellular MicroRNA and P Bodies Modulate Host-HIV-1 Interactions. Molecular Cell. 34(6). 696–709. 320 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact